NAD+ IV Therapy at Rx ReLeaf – Clinical Evaluation Comes First

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme involved in cellular energy metabolism and other normal biological processes. Research is continuing, but marketing claims for NAD+ infusion often extend beyond what high-quality clinical evidence currently supports.

Rx ReLeaf does not promise that NAD+ IV therapy will prevent, diagnose, treat, or cure a disease. A licensed practitioner reviews your health history, medications, goals, and relevant risks before determining whether an available option may be appropriate.

Request an NAD+ Consultation

What to Discuss With Your Practitioner

Your Health History

Current conditions, medications, allergies, prior reactions, pregnancy status, and relevant risks.

Evidence and Uncertainty

What is known, what remains uncertain, and whether another option has stronger evidence for your goal.

Formulation and Source

Ingredients, concentration, pharmacy source when applicable, and whether a formulation is compounded or used off-label.

Monitoring

Potential side effects, expected session length, follow-up, and reasons to change or stop treatment.

How the Process Works

1. Clinical Review

A licensed practitioner reviews your information and determines whether an evaluation, examination, or testing is needed.

2. Informed Decision

You receive information about reasonable alternatives, potential risks, uncertainty, cost, and what the service can and cannot be expected to do.

3. Supervised Session

If treatment is appropriate, trained staff monitor the session under applicable clinical protocols.

Important Medication Information

Some NAD+ formulations may be compounded for an individual patient. A finished compounded drug is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. A practitioner can explain the specific formulation and whether any use is off-label.

Results vary. NAD+ therapy should not replace established medical care, recommended screening, emergency treatment, or treatment prescribed for a diagnosed condition.

Read the full Medical Disclaimer.